Definium Therapeutics, Inc.
DFTX
$17.64
-$0.45-2.49%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.44M | -67.27M | -42.74M | -23.35M | -34.74M |
| Total Depreciation and Amortization | -- | -- | -- | -- | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.75M | 29.60M | 5.06M | -3.61M | 9.62M |
| Change in Net Operating Assets | -4.29M | 8.10M | 8.09M | -2.46M | -225.00K |
| Cash from Operations | -42.98M | -29.57M | -29.60M | -29.42M | -25.35M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.98M | 15.41M | -39.54M | -162.46M | -- |
| Cash from Investing | 34.98M | 15.41M | -39.54M | -162.46M | -- |
| Total Debt Issued | 0.00 | 0.00 | 42.00M | -- | 0.00 |
| Total Debt Repaid | 0.00 | 0.00 | -22.00M | -- | -- |
| Issuance of Common Stock | 261.81M | 749.00K | 97.00K | 1.00M | 3.88M |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -15.95M | 0.00 | -447.00K | -- | -75.00K |
| Cash from Financing | 245.87M | 749.00K | 19.65M | 1.00M | 3.81M |
| Foreign Exchange rate Adjustments | 1.00K | -21.00K | 25.00K | -12.00K | 1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 237.88M | -13.43M | -49.46M | -190.89M | -21.54M |